CIHR - Team Grant: Diabetes Mechanisms and Translational Solutions

Updated Information

Updated deadlines:

  • New Internal Deadline - Letter of Intent: December 2, 2020  11:59 
  • External Deadline - Letter of Intent: December 28, 2021 - updated to December 9, 2020 7:59pm
  • Internal Deadline - Application: December 24, 2021 -  updated to July 6, 2021 11:59pm
  • External Deadline - Application: December 31, 2021 - updated to July 13, 2021  7:59pm
  • Mitacs


The CIHR Institute of Nutrition, Metabolism and Diabetes, Institute of Genetics, Institute of Infection and Immunity, Institute of Indigenous Peoples Health, Institute of Aging, Institute of Circulatory and Respiratory Health, Institute of Gender and Health and Institute of Musculoskeletal Health and Arthritis, in partnership with Diabetes Canada, Fonds de recherche du Québec–Santé (FRQS), Génome Québec JDRF Canada, Kidney Foundation of Canada (KFOC) and Mitacs

For More Information

For additional information, please visit the program's websites for

  • Program guidelines
  • Application forms
  • Evaluation criteria


As part of 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, the Team Grants in Diabetes Mechanisms and Translational Solutions will support multi-disciplinary research to better understand the underlying causes and pathophysiology of diabetes, and develop improved prevention and treatment approaches for diabetes. For the purposes of this Initiative, diabetes includes all forms of diabetes mellitus, its complications and co-morbidities. Mechanistic research is defined as studies designed to understand the pathophysiology of diabetes, its complications and co-morbidities. Translational research is defined as research that advances effective translation and application of knowledge across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes.

Patient engagement is a requirement for this funding opportunity. Patient engagement is about meaningful collaboration between researchers and patients, in this case, people with diabetes representative of the population being studied. Recognizing that with some types of research it may be easier to engage patients than with other types of research, people with diabetes should be engaged as appropriate for the type of research being proposed, for example, by contributing to identifying research questions and priority setting, and contributing to governance of the research and even performing certain parts of the research itself. This type of participation helps to ensure that the research being conducted is relevant and valuable to the people that it affects. People with diabetes engaged in research proposals can also collaborate with the research team to summarize or share the results with target audiences (especially other people with diabetes) and with policy-makers or other decision-makers who may apply the results in a health or community setting. For more information about the full scope of patient engagement, please see CIHR’s Patient Engagement Framework.


  1. The Nominated Principal Applicant must be an independent researcher appointed at an eligible institution (see the CIHR Application Administration Guide – Part 4) at the time of application.
  2. Research Teams must be comprised of no more than 4 Principal Applicants in addition to the Nominated Principal Applicant, and based in more than 1 province. Co-Applicants, Collaborators and knowledge users may be included in the Research Team as appropriate.
  3. The Research Team must include a Sex and Gender Champion listed as a Principal Applicant. The Champion will be a researcher who possesses or acquires expertise in the study of sex as a biological variable and/or gender as a social determinant of health in relation to diabetes research. See Additional Information for further important information on the Champion role.
  4. In addition, each Research Team must include a minimum of one Early Career Researcher in the role of Principal Applicant or Co-Applicant. The Early Career Researcher(s) must be eligible at the time of the full application deadline date.
  5. The Nominated Principal Applicant and all Principal Applicants must have successfully completed one of the sex- and gender-based analysis training modules available online through the CIHR Institute of Gender and Health and submit a Certificate of Completion, at the LOI stage. Select and complete the training module most applicable to your research project. Applicants are encouraged to review the “How to integrate sex and gender in research” section on the CIHR website.
  6. Any research applications involving Indigenous Peoples must include a knowledge user who self-identifies as Indigenous (First Nations, Inuit or Métis) or provides evidence of having meaningful and culturally-safe* involvement with Indigenous Peoples.
  7. The Nominated Principal Applicant must engage patients/people affected by diabetes representative of the populations being studied as part of their team in a manner appropriate to the research being proposed.
  8. An applicant can only submit one application as an NPA, but can participate in any number of applications in other applicant roles.

Additional Partner Funding Eligibility


  • Applicants must contact a Mitacs’ Business Development representative by May 13, 2021. The Mitacs representative will share the Mitacs Application Form and provide support in its completion.
  • Mitacs will confirm eligibility and compliance with Accelerate and/or Elevate program requirements.
  • Once the form is completed, applicants must then send it back to a Mitacs’ Business Development representative so they can pre-review the information for completeness.
  • Applicants must include the requested intern(s) on their budget and the completed Mitacs Application Form with their CIHR full application (see How to Apply section).

Funding Availability

The total amount available at the LOI stage is $200,000, enough to fund approximately 20 LOIs.

At the full application stage, a total of up to $22,000,000 is available, enough to fund up to 10 grants.

Maximum Project Value

The maximum amount per grant is $400,000 per year OR a total up to of $2,000,000 per grant (not including Supplementary Partner Funding).

Indirect Costs


Project Duration

5 years

Special Notes

Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.


If College-level review is required, your College will communicate its earlier internal deadlines.

Internal Deadline

Applicant to submit a copy of application, routing slip and signature page, letter from collaborators along with a complete OR5 form

External Deadline

Letter of Intent: Applicant to submit complete Letter of Intent (LOI) to CIHR using on line application site ResearchNet

Letter of Intent, follow the instructions in the Team Grants/ Emerging Team Grants - ResearchNet "Letter of Intent" Phase Instructions Checklist along with any other instructions under "Specific Instructions"

Internal Deadline

Application if Invited: Applicant to submit a copy of application along with the routing slip, co applicant signature page and Institution Paid page to:

External Deadline

Application if Invited: Applicant to submit complete application including routing slip and signature pages via ResearchNet.

Full Application, follow the instructions in the Team Grants / Emerging Team Grants – ResearchNet “Application” Phase Instructions along with any additional instructions found below under “Specific Instructions”.

Information For Co-applicants

If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).

For Questions, please contact

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178

For service hours, please consult our Contact us page.

For all inquiries related to Mitacs, please contact:

Simon Bousquet
Senior Director, Business Development Operations, Mitacs
Telephone: 819.571.2936

Office of Research

Ornella McCarron, Grants Officer
Research Services Office
519-824-4120 x52832

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences